BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension

Clinical trial NCT00910429 · COMPLETED

Trial details

NCT number: NCT00910429
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2009-07-01
Primary completion: 2019-08-19
Enrollment: 237

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.